{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:08:35Z","timestamp":1791464915911,"version":"4.3.4"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Objectives:<\/jats:bold> Autonomic dysfunction is a common symptom of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis; however, it has been poorly researched. The purpose of this study was to compare the clinical features, tumor occurrence, intensive care unit (ICU) admission, mechanical ventilation, imaging assessment, cerebrospinal fluid examination, disease severity, and immunotherapy in patients with anti-NMDAR encephalitis with or without autonomic dysfunction.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A retrospective study of anti-NMDAR encephalitis patients diagnosed between January 2016 and April 2020 was performed at the First Affiliated Hospital of Zhengzhou University. Patients were divided into two groups according to whether they had autonomic dysfunction, and their clinical features, treatment, and prognosis were compared.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 119 patients with anti-NMDAR encephalitis were included in this study. Seventy-three patients (61.3%) had autonomic dysfunction, while the remaining 46 (38.7%) did not. Sinus tachycardia (69.9%) was the autonomic dysfunction with the highest incidence, while the incidences of symptoms including constipation, central hypopnea, and others gradually decreased. Compared to the group without autonomic dysfunction, the prevalence of the main clinical symptoms such as epileptic seizure (<jats:italic>P<\/jats:italic> = 0.003), involuntary movement (<jats:italic>P<\/jats:italic> = 0.028), and decreased consciousness (<jats:italic>P<\/jats:italic> &amp;lt; 0.001) were higher in the group with autonomic dysfunction, which also more frequently presented with complications such as pulmonary infection (<jats:italic>P<\/jats:italic> &amp;lt; 0.001) and abnormal liver function (<jats:italic>P<\/jats:italic> = 0.001). Moreover, the rates of ICU admission (<jats:italic>P<\/jats:italic> &amp;lt; 0.001) and mechanical ventilation (<jats:italic>P<\/jats:italic> = 0.001), as well as the modified Rankin scale (mRS) scores at admission (<jats:italic>P<\/jats:italic> &amp;lt; 0.001), maximum mRS scores during the course of disease (<jats:italic>P<\/jats:italic> &amp;lt; 0.001), and mRS scores at discharge (<jats:italic>P<\/jats:italic> &amp;lt; 0.001) were higher in the patients with autonomic dysfunction than in those without. The number of patients in the autonomic dysfunction group who underwent \u22652 immunotherapies was also higher than that in the group without autonomic dysfunction (<jats:italic>P<\/jats:italic> &amp;lt; 0.001).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Sinus tachycardia is the most common type of autonomic dysfunction in anti-NMDAR encephalitis. Compared to patients without autonomic dysfunction, those with autonomic dysfunction had a higher incidence of epilepsy, involuntary movements, decreased consciousness, pulmonary infections, abnormal liver function, ICU admissions, and mechanical ventilation; moreover, the severity of the disease was greater, and their prognosis worse. Therefore, such patients require intensive immunotherapy.<\/jats:p>","DOI":"10.3389\/fneur.2021.609750","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T18:52:16Z","timestamp":1612810336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Clinical Study of Autonomic Dysfunction in Patients With Anti-NMDA Receptor Encephalitis"],"prefix":"10.3389","volume":"12","author":[{"given":"Lulu","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e514","DOI":"10.1212\/NXI.0000000000000514","article-title":"Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment","volume":"6","author":"Schubert","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.autneu.2015.08.002","article-title":"Cardiac sympathetic dysfunction in anti-NMDA receptor encephalitis","volume":"193","author":"Byun","year":"2015","journal-title":"Auton Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","article-title":"Prognosticating autoimmune encephalitis: a systematic review","volume":"96","author":"Broadley","year":"2019","journal-title":"J Autoimmun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1161\/STROKEAHA.117.017866","article-title":"Evolution of the Modified Rankin Scale and its use in future stroke trials","volume":"48","author":"Broderick","year":"2017","journal-title":"Stroke."},{"key":"B8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/ane.12723","article-title":"Risk factors for mortality in patients with anti-NMDA receptor encephalitis","volume":"136","author":"Chi","year":"2017","journal-title":"Acta Neurol Scand."},{"key":"B9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7506590","DOI":"10.1155\/2020\/7506590","article-title":"Current progress on assessing the prognosis for anti-N-Methyl-D-aspartate receptor (NMDAR) Encephalitis","volume":"2020","author":"Wang","year":"2020","journal-title":"BioMed Res Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10286-012-0184-4","article-title":"Anti-NMDA receptor encephalitis with paroxysmal sympathetic hyperactivity: an under-recognized association?","volume":"23","author":"Hinson","year":"2013","journal-title":"Clin Auton Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.brainres.2008.10.059","article-title":"Mechanism of heart rate responses elicited by chemical stimulation of the hypothalamic paraventricular nucleus in the rat","volume":"1248","author":"Kawabe","year":"2009","journal-title":"Brain Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.26355\/eurrev_201912_19801","article-title":"Focus on autonomic dysfunctions in anti-NMDAR encephalitis: a case report","volume":"23","author":"Ren","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S0025-6196(12)62272-1","article-title":"The central autonomic network: functional organization, dysfunction, and perspective","volume":"68","author":"Benarroch","year":"1993","journal-title":"Mayo Clin Proc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10286-006-0277-z","article-title":"Seizures and syncope: anatomic basis and diagnostic considerations","volume":"16","author":"Britton","year":"2006","journal-title":"Clin Auton Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.mehy.2012.09.004","article-title":"The human extrapyramidal system","volume":"79","author":"De Oliveira-Souza","year":"2012","journal-title":"Med Hypotheses."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/mds.22073","article-title":"The distinctive movement disorder of ovarian teratoma-associated encephalitis","volume":"23","author":"Kleinig","year":"2008","journal-title":"Mov Disord."},{"key":"B19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10286-020-00698-x","article-title":"Sudor Anglicus: an epidemic targeting the autonomic nervous system","volume":"30","author":"Cheshire","year":"2020","journal-title":"Clin Auton Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e13136","DOI":"10.1111\/jsr.13136","article-title":"Altered structure and functional connectivity of the central autonomic network in idiopathic rapid eye movement sleep behaviour disorder","volume":"30","author":"Li","year":"2020","journal-title":"J Sleep Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1055\/s-2007-1012277","article-title":"Physiologic implications of the autonomic aberrations in cystic fibrosis","volume":"18","author":"Davis","year":"1986","journal-title":"Horm Metab Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s005350050126","article-title":"Hepatocyte proliferation in rats after ventromedial hypothalamic lesions: immunoreactivity patterns of proliferating cell nuclear antigen (PCNA)","volume":"33","author":"Kiba","year":"1998","journal-title":"J Gastroenterol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3748\/wjg.v24.i15.1616","article-title":"Autonomic nervous system network and liver regeneration","volume":"24","author":"Kamimura","year":"2018","journal-title":"World J Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neucli.2020.09.004","article-title":"Computerized dynamic pupillometry as a screening tool for evaluation of autonomic activity","volume":"50","author":"Venkata Sivakumar","year":"2020","journal-title":"Clin Neurophysiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10286-020-00691-4","article-title":"Cardiovascular autonomic function testing in multiple system atrophy and Parkinson's disease: an expert-based blinded evaluation","volume":"30","author":"Leys","year":"","journal-title":"Clin Auton Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1038\/s41598-020-62225-2","article-title":"Assessing autonomic function from electrodermal activity and heart rate variability during cold-pressor test and emotional challenge","volume":"10","author":"Ghiasi","year":"2020","journal-title":"Sci Rep."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.609750\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T18:52:19Z","timestamp":1612810339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.609750\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":26,"alternative-id":["10.3389\/fneur.2021.609750"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.609750","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"article-number":"609750"}}